Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1201-1210 of 1,396) with videos related to

Pageof 140
Sort By:
Nature Communications|March 25, 2018
Mice lacking the mitochondrial exonuclease MGME1 accumulate mtDNA deletions without developing progeriaStanka Matic, Min Jiang, Thomas J Nicholls, et al.
Atherosclerosis|April 22, 2022
Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registryHayato Nakamura, Yu Kataoka, Stephen J Nicholls, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Smart Nonuniformity: Calibration of Sequencing Depth of a Targeted Gene Panel to Simultaneously Detect Somatic and Germline VariantsRobert L O'Reilly, Philip Harraka, Jared Burke, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.
British Journal of Pharmacology|June 30, 2009
Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposureCaroline Düringer, Gunilla Grundström, Eylem Gürcan, et al.
American Heart Journal|July 19, 2025
Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristicsCian P McCarthy, Christie M Ballantyne, Ron Blankstein, et al.
JAMA|June 24, 2023
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant PatientsSteven E Nissen, Venu Menon, Stephen J Nicholls, et al.
JAMA|April 1, 2014
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trialA Michael Lincoff, Jean-Claude Tardif, Gregory G Schwartz, et al.
American Journal of Preventive Cardiology|June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR TrialsChristie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Pageof 140

Showing results (1201-1210 of 1,396) with videos related to

Sort By:
Pageof 140
Nature Communications|March 25, 2018
Mice lacking the mitochondrial exonuclease MGME1 accumulate mtDNA deletions without developing progeriaStanka Matic, Min Jiang, Thomas J Nicholls, et al.
Atherosclerosis|April 22, 2022
Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registryHayato Nakamura, Yu Kataoka, Stephen J Nicholls, et al.
The Journal of Molecular Diagnostics : JMD|May 17, 2025
Smart Nonuniformity: Calibration of Sequencing Depth of a Targeted Gene Panel to Simultaneously Detect Somatic and Germline VariantsRobert L O'Reilly, Philip Harraka, Jared Burke, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.
British Journal of Pharmacology|June 30, 2009
Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposureCaroline Düringer, Gunilla Grundström, Eylem Gürcan, et al.
American Heart Journal|July 19, 2025
Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristicsCian P McCarthy, Christie M Ballantyne, Ron Blankstein, et al.
JAMA|June 24, 2023
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant PatientsSteven E Nissen, Venu Menon, Stephen J Nicholls, et al.
JAMA|April 1, 2014
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trialA Michael Lincoff, Jean-Claude Tardif, Gregory G Schwartz, et al.
American Journal of Preventive Cardiology|June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR TrialsChristie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Pageof 140